Expression of RHAMM and WT1 before and after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). - Institut für Experimentelle Gentherapie und Tumorforschung

Casalegno-Garduño R, Meier C, Mani J, Borchert K, Hilgendorf I, Gross Y, Filipowska A, Koczan D, Spitschak A, Linnebacher M, Schmitt A, Pützer BM, Schmitt M.

Expression of RHAMM and WT1 before and after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).

Onkologie. 2011; 34: Supplement 6, 84-84. P299.

2011

Vorheriger Beitrag

ZPI-deficiency results in a high thrombosis risk in generalized Shwartzman reaction.

Nächster Beitrag

Cell specific targeting of hepatic stellate cells as therapeutic approach in liver fibrosis.

Kontakt

Sekretariat

Institut für Experimentelle Gentherapie und Tumorforschung

Sekretariat

Links

News